Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children

BACKGROUND: Rituximab added to chemotherapy prolongs survival among adults with B-cell cancer. Data on its efficacy and safety in children with high-grade, mature B-cell non-Hodgkin’s lymphoma are limited. METHODS: We conducted an open-label, international, randomized, phase 3 trial involving patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:N Engl J Med
Main Authors: Minard-Colin, V., Aupérin, A., Pillon, M., Burke, G.A.A., Barkauskas, D.A., Wheatley, K., Delgado, R.F., Alexander, S., Uyttebroeck, A., Bollard, C.M., Zsiros, J., Csoka, M., Kazanowska, B., Chiang, A.K., Miles, R.R., Wotherspoon, A., Adamson, P.C., Vassal, G., Patte, C., Gross, T.G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7720281/
https://ncbi.nlm.nih.gov/pubmed/32492302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1915315
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados